PharmiWeb.com - Global Pharma News & Resources
03-Jul-2019

Egg Allergy Market Could Exceed USD 2,304.3 Million by 2023| Moderate CAGR 7.10%

Global Egg Allergy Market is expected to reach a market value of USD 2,304.3 million by 2023 from USD 1,635.3 million in 2018, growing at a moderate CAGR of 7.10% during the forecast period.

The Global Egg Allergy Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/11959

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Egg Allergy Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Egg Allergy Market?

What is the market drivers, restrains, opportunities governing the Global Egg Allergy Market?

Which are the largest and the fastest growing segments in the Global Egg Allergy Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-egg-allergy-market-mrfr-11959

Introduction

Eggs are the most common allergy-causing agents, especially in children. Symptoms of egg allergy can occur immediately or within a few minutes or few hours. Egg allergy can affect infants as well as adults. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Egg allergy happens when there is an overreaction to eggs by the immune system. The immune system identifies egg proteins as harmful and triggers an allergic reaction.

The global egg allergy market is expected to reach a market value of USD 2,304.3 million by 2023 from USD 1,635.3 million in 2018, growing at a CAGR of 7.10% during the forecast period. In 2018, the Americas held the highest share of the market, i.e., 39.7%, followed by Europe and Asia-Pacific with 26.6% and 24.5% market shares respectively.

The global egg allergy market has been segmented on the basis of age group, diagnosis amp; treatment, end user, and region.
The global egg allergy market, by age group, has been segmented into children and adults.
The global egg allergy market, by diagnosis has been further segmented into skin test, blood test and food challenge. The treatment segment has been further segmented into medication and oral immunotherapy.
The global egg allergy market, by end user, has been segmented into hospitals amp; clinics, diagnostic centres, and research institute.
The global egg allergy market is expected to reach USD 2,304.3 million by 2023 from USD 1,635.3 million in 2018; it is expected to register a CAGR of 7.10% during the forecast period from 2018 to 2023.

Key Players

Sanofi S.A., Genentech, Inc., Quest Diagnostics, ImmuneTech, HYCOR Biomedical, Kaleo, Inc., Alletess Medical Laboratory, Creative Diagnostics, Imutest Ltd, Mylan N. V., and Impax Laboratories.

Study objectives

bull; To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the egg allergy market
bull; To provide insights into factors affecting the market growth
bull; To analyze the global egg allergy market based on various tools such as supply chain analysis and Porter's five force analysis
bull; To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
bull; To provide country-level analysis of the market with respect to the current market size and future perspective
bull; To provide country-level analysis of the market for segments by age group, diagnosis amp; treatment, end user, and region
bull; To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
bull; To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the egg allergy market

Target Audience

bull; Hospitals
bull; Association
bull; Egg Allergy Products Manufacturing Companies

Key Findings

bull; The global egg allergy market is expected to reach USD 2,304.3 million by 2023 at a CAGR of 7.10% from 2017 to 2023
bull; On the basis of age group, children accounted for the largest market share at a CAGR of 7.34% by 2023
bull; On the basis of diagnosis amp; treatment, diagnosis accounted for the largest market share at a CAGR of 7.37% by 2023
bull; On the basis of end-user, hospitals amp; clinics accounted for the largest market share at a CAGR of 6.81% by 2023
bull; The Americas is expected to hold the largest share of the global egg allergy market at a CAGR of 6.46% by 2023
bull; Asia-Pacific is the fastest growing market, which is expected to grow at a CAGR of 8.71% by 2023

Regional Analysis

bull; Americas
o North America
 US
 Canada
o South America
bull; Europe
o Western Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Western Europe
o Eastern Europe
bull; Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
bull; The Middle East amp; Africa
o Middle East
o Africa

Table Of Contents

Global Egg Allergy Market Research Report Forecast to 2023

1 Report Prologue

2 Executive Summary

3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions amp; Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure

4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model

5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing prevalence of egg allergy
5.2.2 Improved allergy diagnosis
5.3 Restraints
5.3.1 Lack of awareness in developing countries
5.3.2 High Cost
5.4 Opportunity
5.4.1 Technological Advancements in screening
5.5 Challenges
5.5.1 Technical difficulties during testing

6 Market Factor Analysis
6.1 Value Chain Analysis
6.2 Ramp;D
6.3 Product Development
6.4 Manufacturing
6.5 Marketing and Distribution
6.6 Porterrsquo;s Five Forces Analysis
6.6.1 Bargaining Power of Suppliers
6.6.2 Bargaining Power of Buyers
6.6.3 Threat of New Entrants
6.6.4 Threat of Substitutes
6.6.5 Intensity of Rivalry
6.7 Investment Opportunities
6.8 Demand amp; Supply: Gap Analysis
6.9 Price Analysis

7 Global Egg Allergy Market, By Age group
7.1 Introduction
7.1.1 Children (0-18 years)
7.1.2 Adults (18 + years)

8 Global Egg Allergy Market, By Diagnosis amp; Treatment
8.1 Introduction
8.1.1 Diagnosis
8.1.1.1 Skin Test
8.1.1.2 Blood Test
8.1.1.3 Food Challenge
8.1.2 Treatment
8.1.2.1 Medication
8.1.2.2 Oral immunotherapy

9 Global Egg Allergy Market, By End User
9.1 Introduction
9.1.1 Hospitals amp; Clinics
9.1.2 Diagnostic Centres
9.1.3 Research institute

10 Global Egg Allergy Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 France
10.3.1.2 Germany
10.3.1.3 Italy
10.3.1.4 U.K
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East and Africa
10.5.1 Middle east
10.5.2 Africa

11 Competitive Landscape
11.1 Company Market Share Analysis
11.1.1 Introduction

12 Company Profiles
12.1 Sanofi S.A.
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Genentech, Inc.
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Quest Diagnostics
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Development
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 ImmuneTech
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Development
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 HYCOR Biomedical
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Development
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Kaleo, Inc.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Alletess Medical Laboratory
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Creative Diagnostics
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Imutest Ltd
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.10 Mylan N. V.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Impax Laboratories
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products Offering
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy

13 Appendix
13.1 Discussion Blue Print

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11959

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 03-Jul-2019